Session highlights: practical aspects of immunotherapy in multiple myeloma

Session highlights: disease monitoring in multiple myelomaПодробнее

Immunotherapy in multiple myeloma #knowmyelomaПодробнее

Highlights from the IMW 2021 meetingПодробнее

Session highlights: integrating cellular therapy in myelomaПодробнее

Cellular immunotherapy highlights from EBMT 2023Подробнее

Highlights in multiple myeloma from ASH 2021: cilta-cel, bispecific antibodies & disease biologyПодробнее

IMS session highlights: clinical challenges in multiple myelomaПодробнее

Practical Information on Immunotherapy UseПодробнее

The role of immunotherapy in multiple myelomaПодробнее

The future of immunotherapy in multiple myelomaПодробнее

Immunotherapy highlights in multiple myeloma at ASH 2016Подробнее

Latest advances in immunotherapy for multiple myeloma: targets, alloCAR-Ts & immunomodulatory drugsПодробнее

The barriers to a cure for multiple myelomaПодробнее

Can immunotherapy cure cancer? #knowmyeloma (multiple myeloma blood cancer)Подробнее

Using single-cell sequencing to define mechanisms of progression from SMM to myelomaПодробнее

Smoldering myeloma: highlights from ASH 2020Подробнее

Myeloma 2017 day 1 highlights: immunotherapy advances, a new MM subtype and liquid biopsiesПодробнее

Asia-Pacific approaches to myeloma trialsПодробнее

Highlights in the myeloma field to come at ASH 2020Подробнее